Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study

Amit Bar-Or, Michal Dufek, Hrvoje Budinčević, Jelena Drulović, Mario Habek, Le H. Hua, Martin S. Weber, Piia Thomas, Julie Napieralski, Maresa Caunt Mitzner, John N. Ratchford, David Clayton, Christopher Harp, Denison Kuruvilla, Qi Qi, Ying-Fang Chen, Yan Xu, Alexandra Goodyear, Jiwon Oh, Sanja Grgic, Hrvoje Budincevic, Mario Habek, Spomenka Kidemet Piskac, Vladimira Vuletic, Radek Ampapa, Michal Dufek, Jana Lizrova Preiningerova, Zbyšek Pavelek, Jelena Drulovic, Smiljana Kostic, Svetlana Miletic Drakulic, Dusica Smiljanic-Miljkovic, Slobodan Vojinovic, Viera Hančinová, Jack Florin, Le Hua, Kenneth Sharlin